论文部分内容阅读
大多数抗肿瘤药物可以引起不同程度的骨髓抑制,这往往导致治疗中断,直接影响了化疗药物对肿瘤治疗的效果。我们采用军事医学科学院放射医学研究所研制的重组人粒细胞集落刺激因子(ｒｈＧＣＳＦ)治疗恶性肿瘤化疗所致白细胞减少症60例,并与应用进口ｒｈＧＣＳＦ的30例患者对照,?
Most anti-tumor drugs can cause different degrees of myelosuppression, which often leads to interruption of treatment, which directly affects the effect of chemotherapy drugs on tumor therapy. We used the Institute of Radiation Medicine Military Academy of Medical Sciences developed recombinant human granulocyte colony stimulating factor (rhGCSF) 60 cases of chemotherapy-induced leucopenia in patients with malignant tumors, and with the application of imported rhGCSF in 30 patients control?